Despite A 26% Growth Over The Last Month CRISPR Stock May Continue To Rise

The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, has seen a solid 26% rise over the last twenty-one trading sessions, and we believe that the stock may continue to rally upward in the near term...